Saudi Arabia reports 5 more MERS cases

Robert Roos | News Editor | CIDRAP News
MERS-CoV
Saudi Arabia map
Saudi Arabia map

mjbs/ iStock

Saudi Arabia reported five more MERS cases over the weekend, raising the total for this month to 37, but no new cases were announced today.

All five patients are men who are in stable condition, the Saudi Ministry of Health (MOH) reported. None of them are healthcare workers.

The two cases reported Mar 14 involve two men, a 47-year-old in Hofuf and a 60-year-old in Taimah, the ministry said. Both had preexisting conditions. The older man had a history of exposure to animals before he got sick, but neither of them had any other known exposure risks.

Yesterday the MOH reported the illness in a 44-year-old expatriate in Khafji, a town on the Kuwait border, and in two Saudis, ages 56 and 27, in Riyadh. The only MERS-CoV (Middle East respiratory syndrome) risk factor among them was exposure to animals for the Khafji man.

The MOH also reported three deaths over the weekend. The victims were all Saudis who lived in Riyadh and were 59, 61, and 62 years old. Officials reported the recovery of two other patients, a 46-year-old foreign woman and a 56-year-old Saudi man, both in Riyadh.

The latest developments brought the MOH's MERS count to 957 cases, including 516 deaths, 416 patients recovered, and 25 still in treatment or home isolation.

Weekly summary

In other news, the MOH today released its weekly summary of MERS cases, providing some data on 15 cases reported from Mar 8 through 14.

They involved 10 men and 5 women ranging in age from 21 to 72 years. Ten cases occurred in Riyadh, the epicenter of MERS activity, with 2 in Al-Ahsa and 1 each in Jeddah, Al-Qassim, and Tabuk. By nationality, the patients included 10 Saudis, 2 Sudanese, 1 Filipino, 1 Egyptian, and 1 Yemeni.

Of the Riyadh cases, 3 were community-acquired, 2 were in healthcare workers, 3 were hospital-acquired, 1 involved contact with a patient at home, and another was still being investigated. The Al-Ahsa and Jeddah cases were community-acquired, while the Al-Qassim case was under investigation. No exposure information was listed for the Tabuk one.

See also:

Mar 16 MOH statement

Mar 15 MOH statement

Mar 14 MOH statement

Mar 15 MOH weekly update

This week's top reads

  1. FDA significantly limits COVID-19 vaccine recommendations

    Critics said today’s announcement is more evidence of the current administration’s willingness to undermine public trust in vaccines.

    Stephanie Soucheray
    FDA building

  2. Woman dies of Creutzfeldt-Jakob almost 50 years after taking prion-contaminated growth hormone

    The patient, who presented with gait imbalance and tremors, wasn't diagnosed until she was in a coma, shortly before she died.

    Mary Van Beusekom
    Woman in hospital bed

  3. Meta-analysis: Zika-infected pregnant moms 4 times more likely to have babies with microcephaly

    Five of 22 studies noted that over 50% of newborns had microcephaly, and the same number of studies observed that over 5% had congenital Zika syndrome. 

    Mary Van Beusekom

  4. HHS expected to discontinue COVID vaccine recommendations for some groups

    When CDC advisers widened their recommendation in 2023, most members were swayed by data, including those for long COVID, showing that no group is at low risk for the virus.

    Lisa Schnirring

  5. WHO advisers say current strains OK for COVID vaccine production

    Current vaccine strains show high neutralization against the latest variants, but the LP.8.1 antigen may provide similar or moderately higher cross-reactive antibody response.

    Lisa Schnirring
    senior vaccination

  6. US measles outbreak grows to 1,024 cases

    Texas remains the country's hot spot, with 718 cases. 

    Chris Dall
    Doctor treating child with measles

  7. Moderna pulls licensing submission for combo flu-COVID vaccine

    Moderna's combination vaccine was intended for adults 50 and older. 

    Stephanie Soucheray

  8. Flu vaccine efficacy 41% overall and 26% in older adults, per 2023-24 estimates

    Estimated effectiveness was 68% against influenza B and 32% against type A.

    Mary Van Beusekom
    Flu shot going into arm

  9. Mpox activity escalates in Sierra Leone

    Responding to the surge is a major focus, partly to prevent the spread to other West African countries. 

    Lisa Schnirring
    mpox virus

  10. Testing ties Listeria outbreak to ready-to-eat sandwiches

    An earlier investigation hinted at hospital food as a source, but evidence didn't reveal a specific item.

    Lisa Schnirring

Our underwriters